We use cookies to give you the best online experience. By using our website you agree to our use of cookies in accordance with our cookie policy. Learn more OK
Roche Menu Search Global Web Site : Products

You are here:

  1. Products
  2. Valcyte
Roche Language: DE
  • Home
  • About Roche
  • Products
  • Sustainability
  • Research & Development
  • Partnering
  • Media
  • Investors
  • Careers

Valcyte (Valganciclovir)

Doctor with Patient

Used for the prevention of cytomegalovirus (CMV) infections in kidney, heart, and pancreas transplant patients. Used in the treatment of CMV retinitis in patients with AIDS.

Share
  • Share via email
  • Share on Facebook
  • Share on Twitter
  • Share on LinkedIn
  • Share on Google+
  • Share on Xing
Close

Looking for more detailed information?

For regulatory reasons we are not able to provide further details on our products on this website, but more information may be available on our local website.
Please choose your country of residence to access available information in your language.

Related Links

  • www.rochetransplant.com
  • © 2019 F. Hoffmann-La Roche Ltd
  • 25.06.2019
  • Legal Statement
  • Privacy Policy

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.

  • Twitter
  • LinkedIn
  • Facebook
  • YouTube